Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01674023
Other study ID # No.518
Secondary ID
Status Completed
Phase N/A
First received August 23, 2012
Last updated March 31, 2015
Start date August 2012

Study information

Verified date March 2015
Source Kyorin University
Contact n/a
Is FDA regulated No
Health authority Japan: Institutional Review Board
Study type Observational

Clinical Trial Summary

MicroRNAs are important regulators of many cellular functions but their expression profile in human vitreous is still unclear. Aim of this study is to investigate microRNA expression profile by PCR in human vitreous of patients with various vitreoretinal disorders and compare with that of patients with macular holes which are suggested to be similar to that of healthy subjects.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- any patients undergoing vitrectomy for various vitreoretinal diseases

Exclusion Criteria:

- previously vitrectomized eyes

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms

  • MicroRNA Expression Profile in Human Vitreous of Various Vitreoretinal Diseases

Locations

Country Name City State
Japan Kyorin University School Of Medicine Mitakasi Sinkawa6-20-2 Tokyo

Sponsors (1)

Lead Sponsor Collaborator
Kyorin University

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary MicroRNA expression profile in human vitreous investigated by PCR 1month No